LEO Pharma’s Tralokinumab-ldrm Autoinjector Now Available in US for Adults With Moderate to Severe Atopic Dermatitis
The Adbry 300 mg/2 mL autoinjector reduces the number of self injections required for patients, who currently have a 150mg/1mL pre-filled syringe available.